Psychemedics Corp (PMD)
2.57
-0.05
(-1.91%)
USD |
NASDAQ |
May 02, 15:14
Psychemedics Cash from Financing (Quarterly): -0.073M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.073M |
| September 30, 2023 | -0.074M |
| June 30, 2023 | -0.928M |
| March 31, 2023 | -0.072M |
| December 31, 2022 | -0.582M |
| September 30, 2022 | -0.568M |
| June 30, 2022 | -0.60M |
| March 31, 2022 | -0.174M |
| December 31, 2021 | -0.515M |
| September 30, 2021 | -0.177M |
| June 30, 2021 | -0.172M |
| March 31, 2021 | -0.171M |
| December 31, 2020 | -0.172M |
| September 30, 2020 | -0.169M |
| June 30, 2020 | 2.004M |
| March 31, 2020 | -1.162M |
| December 31, 2019 | 0.321M |
| September 30, 2019 | -1.098M |
| June 30, 2019 | -1.13M |
| March 31, 2019 | -1.095M |
| December 31, 2018 | -2.023M |
| September 30, 2018 | -1.234M |
| June 30, 2018 | -1.319M |
| March 31, 2018 | -1.063M |
| December 31, 2017 | 1.084M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.926M |
| June 30, 2017 | -2.509M |
| March 31, 2017 | -1.105M |
| December 31, 2016 | -2.663M |
| September 30, 2016 | -1.255M |
| June 30, 2016 | -1.40M |
| March 31, 2016 | -0.608M |
| December 31, 2015 | -1.190M |
| September 30, 2015 | -0.0648M |
| June 30, 2015 | -1.294M |
| March 31, 2015 | -1.156M |
| December 31, 2014 | -1.210M |
| September 30, 2014 | -0.1555M |
| June 30, 2014 | 4.056M |
| March 31, 2014 | 0.3025M |
| December 31, 2013 | -0.8168M |
| September 30, 2013 | -0.7847M |
| June 30, 2013 | -0.902M |
| March 31, 2013 | -0.7855M |
| December 31, 2012 | -0.7895M |
| September 30, 2012 | -0.7909M |
| June 30, 2012 | -0.8841M |
| March 31, 2012 | -0.7853M |
| December 31, 2011 | -0.6282M |
| September 30, 2011 | -0.651M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.162M
Minimum
Mar 2020
2.004M
Maximum
Jun 2020
-0.2901M
Average
-0.174M
Median
Mar 2022
Cash from Financing (Quarterly) Benchmarks
| Delcath Systems Inc | 0.001M |
| Star Equity Holdings Inc | 0.987M |
| Exact Sciences Corp | 10.04M |
| CytoSorbents Corp | 12.21M |
| Progyny Inc | -5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.662M |
| Cash from Investing (Quarterly) | 0.005M |
| Free Cash Flow | -1.637M |
| Free Cash Flow Per Share (Quarterly) | 0.1097 |
| Free Cash Flow to Equity (Quarterly) | 0.711M |
| Free Cash Flow to Firm (Quarterly) | 0.637M |
| Free Cash Flow Yield | -11.10% |